e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Advances in noninvasive monitoring of airway inflammation and obstruction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring the effect of fixed combination therapy by exhaled biomarkers in asthmatic children
E. Barát, E. Huszár, M. Valyon, E. Péterfy, G. Baktai, I. Horváth (Budapest, Hungary)
Source:
Annual Congress 2005 - Advances in noninvasive monitoring of airway inflammation and obstruction
Session:
Advances in noninvasive monitoring of airway inflammation and obstruction
Session type:
Poster Discussion
Number:
1461
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Barát, E. Huszár, M. Valyon, E. Péterfy, G. Baktai, I. Horváth (Budapest, Hungary). Monitoring the effect of fixed combination therapy by exhaled biomarkers in asthmatic children. Eur Respir J 2005; 26: Suppl. 49, 1461
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
The suitability of exhaled breath compounds to identify children with exercise induced bronchoconstriction is modulated by the use of inhaled corticosteroids.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Measurement of exhaled NO to monitor symptom-free asthmatic children after voluntary cessation of inhaled steroids
Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Year: 2003
Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001
Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients
Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Year: 2012
Exhaled NO predicts relapse after discontinuation of inhaled steroids in asthmatic children
Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Year: 2003
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients
Source: International Congress 2017 – Management of COPD
Year: 2017
Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005
F
ENO
as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma
Source: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020
Year: 2020
Influence of oral steroid use in difficult-to-control asthma patients on metabolomic profile of oxidative stress in exhaled breath condensate (EXAIR project)
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
Effect of tiotropium on exhaled breath temperature in patients with COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Measurement of exhaled nitric oxide can not reliably predict exacerbations in school-aged asthmatic children using inhaled corticosteroids
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Comparison of nasal steroids, antileukotrienes and combination therapy in seasonal allergic rhinitis: effect on exhaled breath markers
Source: Eur Respir J 2003; 22: Suppl. 45, 109s
Year: 2003
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019
Year: 2020
Effects of inhaled corticosteroids on breath condensate inflammatory markers in childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 41s
Year: 2005
Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept